Cited by 320CRISPR and Genetic EngineeringBiomedical Ethics and RegulationEthics and bioethics in healthcare

CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool

Open access
Brokowski, Carolyn, Adli, Mazhar·2019·Journal of Molecular Biology

Abstract

With the emergence of CRISPR technology, targeted editing of a wide variety of genomes is no longer an abstract hypothetical, but occurs regularly. As application areas of CRISPR are exceeding beyond research and biomedical therapies, new and existing ethical concerns abound throughout the global community about the appropriate scope of the systems' use. Here we review fundamental ethical issues including the following: 1) the extent to which CRISPR use should be permitted; 2) access to CRISPR applications; 3) whether a regulatory framework(s) for clinical research involving human subjects might accommodate all types of human genome editing, including editing of the germline; and 4) whether international regulations governing inappropriate CRISPR utilization should be crafted and publicized. We conclude that moral decision making should evolve as the science of genomic engineering advances and hold that it would be reasonable for national and supranational legislatures to consider evidence-based regulation of certain CRISPR applications for the betterment of human health and progress.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jmb.2018.05.044

Cites

140 of 140 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

  • Cites a retracted work: 10.1038/nmeth.4293

    Major

    The cited work was retracted on 2018-03-30 (notice 10.1038/nmeth.4293), before this paper was published (2019-01). Its authors could have known.

    Cited work 10.1038/nmeth.4293 · retracted 2018-03-30 · notice 10.1038/nmeth.4293 · this paper published 2019-01

1 of 1

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. 2017, Acad. Med. Sci.

Cited by

Sorted by citations

Authors
Brokowski, C., & Adli, M.
Affiliations
  • Yale University (US)
  • University of Virginia (US)
Corresponding author
Adli, Mazhar
Venue
Journal of Molecular Biology
Publisher
Elsevier BV
Published
2019-01
Volume
431
Issue
1
Pages
88-101
ISSN
0022-2836 (ISSN-L)
OpenAlex
W2807286159
Cited by
320
References
140
Citations by year
2026: 47 · 2025: 70 · 2024: 40 · 2023: 36 · 2022: 28 · 2021: 55 · 2020: 24 · 2019: 17 · 2018: 3
FWCI
2.40
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health/National Cancer Institute (1R01 CA211648-01)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Health Sciences › Medicine › Physiology › Biomedical Ethics and Regulation
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
Keywords
CRISPR, human genome editing, germline editing, clinical research ethics, international regulation, ethical decision-making, genomic engineering
MeSH terms
Gene Editing, Decision Making, Humans, Genome, Human, Translational Research, Biomedical, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review